Targeting hormone refractory advanced prostate cancer with 177Lu labeled humanized antibody huJ591 against prostate specific membrane antigen (PSMA).

被引:0
|
作者
Kostakoglu, L
Vallabhajosula, S
Brandman, S
Kothari, P
Konishi, T
Joyce, M
Bander, NH
Goldsmith, SJ
机构
[1] New York Presbyterian Hosp, Weill Cornell Med Ctr, Dept Radiol, Div Nucl Med, New York, NY USA
[2] New York Presbyterian Hosp, Weill Cornell Med Ctr, Dept Surg, Div Urol Oncol, New York, NY USA
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
430
引用
收藏
页码:132P / 132P
页数:1
相关论文
共 50 条
  • [1] Targeting of hormone refractory prostate cancer with anti-PSMA antibody huJ591 labeled with 111In.
    Kostakoglu, L
    Vallabhajosula, S
    Goldsmith, SJ
    Hamacher, KA
    Smith-Jones, P
    Konishi, T
    Chan, KM
    Nanus, DM
    Bander, NH
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 295P - 295P
  • [2] Clinical use of monoclonal antibody HuJ591 therapy: Targeting prostate specific membrane antigen
    Nanus, DM
    Milowsky, MI
    Kostakoglu, L
    Smith-Jones, PM
    Vallabahajosula, S
    Goldsmith, SJ
    Bander, NH
    JOURNAL OF UROLOGY, 2003, 170 (06): : S84 - S88
  • [3] Radioimmunotherapy of Metastatic Prostate Cancer with Lu-177-DOTA-huJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody
    Vallabhajosula, Shankar
    Nikolopoulou, Anastasia
    Jhanwar, Yuliya S.
    Kaur, Gurveen
    Tagawa, Scott T.
    Nanus, David M.
    Bander, Neil H.
    Goldsmith, Stanley J.
    CURRENT RADIOPHARMACEUTICALS, 2016, 9 (01) : 44 - 53
  • [4] Lutetium-177-labeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 (177Lu-J591) for metastatic non-prostate solid tumors
    Pail, Orrin
    Kaur, Gurveen
    Dyke, Jonathan
    Jhanwar, Yuliya
    Christos, Paul
    Ocean, Allyson
    Shah, Manish
    Shore, Tsiporah
    Schneider, Bryan
    Scheff, Ronald
    Beltran, Himisha
    Ballon, Douglas
    Robinson, Brian
    Nanus, David M.
    Bander, Neil H.
    Tagawa, Scott T.
    CANCER RESEARCH, 2014, 74 (19)
  • [5] Noninvasive Imaging of PSMA in Prostate Tumors with 89Zr-Labeled huJ591 Engineered Antibody Fragments: The Faster Alternatives
    Viola-Villegas, Nerissa Therese
    Sevak, Kuntal K.
    Carlin, Sean D.
    Doran, Michael G.
    Evans, Henry W.
    Bartlett, Derek W.
    Wu, Anna M.
    Lewis, Jason S.
    MOLECULAR PHARMACEUTICS, 2014, 11 (11) : 3965 - 3973
  • [6] Phase 2 trial of 177Lutetium (177Lu) radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody (mAb) J591 (177Lu-J591) in patients (pts) with metastatic androgen-independent prostate cancer (AIPC).
    Morris, M. J.
    Milowsky, M. I.
    Pandit-Taskar, N.
    Divgi, C.
    David, K. A.
    Rozario, C. P.
    Vallabhajosula, S.
    Goldsmith, S. J.
    Scher, H. I.
    Nanus, D. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 244S - 244S
  • [7] Prospects of medium specific activity 177Lu in targeted therapy of prostate cancer using 177Lu-labeled PSMA inhibitor
    Chakraborty, Sudipta
    Chakravarty, Rubel
    Shetty, Priyalata
    Vimalnath, K. V.
    Sen, Ishita B.
    Dash, Ashutosh
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2016, 59 (09): : 364 - 371
  • [8] Pharmacokinetics and biodistribution of 111In-177Lu-labeled J591 antibody specific for prostate-specific membrane antigen:: Prediction of 90Y-J591 radiation dosimetry based on 111In or 177Lu?
    Vallabhajosula, S
    Kuji, I
    Hamacher, KA
    Konishi, S
    Kostakoglu, L
    Kothari, PA
    Milowski, MI
    Nanus, DM
    Bander, NH
    Goldsmith, SJ
    JOURNAL OF NUCLEAR MEDICINE, 2005, 46 (04) : 634 - 641
  • [9] Marked Response to 177Lu Prostate-Specific Membrane Antigen Treatment in Patient With Metastatic Prostate Cancer
    Soydal, Cigdem
    Ozkan, Elgin
    Akyurek, Serap
    Kucuk, Nuriye Ozlem
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (02) : 159 - 160
  • [10] Fact Checking on 177Lu Prostate-Specific Membrane Antigen Nephrotoxicity
    Askari, Emran
    Moghadam, Soroush Zarehparvar
    Aryana, Kamran
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2020, 215 (01) : W2 - W2